Literature DB >> 18387786

The Early Childhood Epilepsy Severity Scale (E-Chess).

Ayla Humphrey1, George B Ploubidis, John R W Yates, Tami Steinberg, Patrick F Bolton.   

Abstract

PURPOSE: We have developed the Early Childhood Epilepsy Severity Scale (E-Chess) to quantify the severity of epilepsy in infants and young children with tuberous sclerosis as an aid to the evaluation of treatment efficacy and the investigation of the influence of epilepsy severity on development.
METHODS: Twenty infants aged 11-36 months with a diagnosis of tuberous sclerosis participated in the study. From the literature, six potential measures of epilepsy severity were identified: time period over which seizures occurred; seizure frequency; number of seizure types; occurrence and duration of status epilepticus; number of anticonvulsant medications used; response to treatment. The variables were given a score, usually from 0 to 3, a higher score indicating greater severity. For each child, these variables were scored over consecutive 1 year time periods by three independent raters. We employed restricted and nonrestricted factor analytic models to identify the latent structure of the six items.
RESULTS: The six severity items had a unidimensional structure. All severity indicators loaded highly on the latent epilepsy severity factor (>0.77), with the exception of the status indicator which had a poor loading (<0.40) and was excluded from further analyses. Goodness of fit indices were all well within the acceptable criteria for model fit. The E-Chess score at 12 months was significantly predictive of scores at 24 and 36 months.
CONCLUSIONS: A single continuous latent variable accounts for the variation in five of the six epilepsy severity indicators under study. These form the Early Childhood Epilepsy Severity Scale. The predictive validity of the E-Chess was satisfactory. The E-Chess provides an epilepsy severity score that can be easily used to assess epilepsy severity in tuberous sclerosis and would merit evaluation in other early onset childhood epilepsies.

Entities:  

Mesh:

Year:  2008        PMID: 18387786     DOI: 10.1016/j.eplepsyres.2008.01.007

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

1.  Repeatability of graph theoretical metrics derived from resting-state functional networks in paediatric epilepsy patients.

Authors:  Michael J Paldino; Zili D Chu; Mary L Chapieski; Farahnaz Golriz; Wei Zhang
Journal:  Br J Radiol       Date:  2017-05-23       Impact factor: 3.039

Review 2.  Severity Assessment in CDKL5 Deficiency Disorder.

Authors:  Scott Demarest; Elia M Pestana-Knight; Heather E Olson; Jenny Downs; Eric D Marsh; Walter E Kaufmann; Carol-Anne Partridge; Helen Leonard; Femida Gwadry-Sridhar; Katheryn Elibri Frame; J Helen Cross; Richard F M Chin; Sumit Parikh; Axel Panzer; Judith Weisenberg; Karen Utley; Amanda Jaksha; Sam Amin; Omar Khwaja; Orrin Devinsky; Jeffery L Neul; Alan K Percy; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-03-27       Impact factor: 3.372

3.  Angelman syndrome in adulthood.

Authors:  Anna M Larson; Julianna E Shinnick; Elias A Shaaya; Elizabeth A Thiele; Ronald L Thibert
Journal:  Am J Med Genet A       Date:  2014-11-26       Impact factor: 2.802

4.  Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.

Authors:  Jacinta Saldaris; Judith Weisenberg; Elia Pestana-Knight; Eric D Marsh; Bernhard Suter; Rajsekar Rajaraman; Gena Heidary; Heather E Olson; Orrin Devinsky; Dana Price; Peter Jacoby; Helen Leonard; Tim A Benke; Scott Demarest; Jenny Downs
Journal:  J Child Neurol       Date:  2021-08-11       Impact factor: 1.987

Review 5.  Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.

Authors:  Elizabeth E Palmer; Katherine Howell; Ingrid E Scheffer
Journal:  Neurotherapeutics       Date:  2021-10-27       Impact factor: 6.088

6.  Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex.

Authors:  Fiona M Baumer; Jurriaan M Peters; Sean Clancy; Anna K Prohl; Sanjay P Prabhu; Benoit Scherrer; Floor E Jansen; Kees P J Braun; Mustafa Sahin; Aymeric Stamm; Simon K Warfield
Journal:  Cereb Cortex       Date:  2018-10-01       Impact factor: 5.357

7.  Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials.

Authors:  Charlotte DiStefano; Rujuta B Wilson; Carly Hyde; Edwin H Cook; Ronald L Thibert; Lawrence T Reiter; Vanessa Vogel-Farley; Joerg Hipp; Shafali Jeste
Journal:  Am J Med Genet A       Date:  2019-10-26       Impact factor: 2.802

8.  The Relationship Between Severity of Epilepsy and Sleep Disorder in Epileptic Children.

Authors:  Maryam Dehghani; Afshin Fayyazi; Fatemeh Cheraghi; Hamideh Hakimi; Somayeh Mosazadeh; Saeideh Almasi
Journal:  Iran J Child Neurol       Date:  2019

9.  Symptom profiles of autism spectrum disorder in tuberous sclerosis complex.

Authors:  Shafali S Jeste; Kandice J Varcin; Gerhard S Hellemann; Amanda C Gulsrud; Rujuta Bhatt; Connie Kasari; Joyce Y Wu; Mustafa Sahin; Charles A Nelson
Journal:  Neurology       Date:  2016-07-20       Impact factor: 9.910

10.  Autism diagnosis differentiates neurophysiological responses to faces in adults with tuberous sclerosis complex.

Authors:  Charlotte Tye; Teresa Farroni; Ágnes Volein; Evelyne Mercure; Leslie Tucker; Mark H Johnson; Patrick F Bolton
Journal:  J Neurodev Disord       Date:  2015-10-07       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.